Hormone Therapy

Government-enacted restrictions have resulted in about half of U.S. children and adolescents aged 10 to 17 years living more than 1 hour from a clinic offering gender-confirming care, according to a research letter published in JAMA.

Past or current use of menopausal hormone therapy is significantly associated with GERD among postmenopausal women, according to results of a systematic review and meta-analysis.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses the role of hormone blocking therapies in prostate cancer care.

CHICAGO—In this video exclusive, Vin Tangpricha, MD, PhD, discusses recent legislation prohibiting or seeking to prohibit physicians from providing gender-confirming care.

Experts from across the field of endocrinology will converge on Chicago beginning Thursday for the 2023 Endocrine Society annual meeting.

Among postmenopausal women, hormone preparations increased lumbar spine bone mineral density and had a protective effect against osteopenia, according to a real-world study published in Menopause.

The North American Menopause Society released its 2023 Nonhormone Therapy Position Statement recommending up-to-date scientific evidence for nonhormonal options for managing menopausal symptoms.

CHICAGO — The odds of having gastric and pancreatic cancers were higher among postmenopausal women on hormone replacement therapy and remained significant after controlling for risk factors, according to data at Digestive Disease Week.

The Healio Editors compiled news on menopause in women’s health for National Women’s Health Week.

Risk for type 2 diabetes with use of menopausal hormone therapy varied by type of HT, according to a retrospective cohort study of women in South Korea published in Menopause.